Structure-activity relationships for kininase II inhibition by lower homologs of the bradykinin potentiating peptide BPP9a
Fisher, G.H.; Ryan, J.W.; Martin, L.C.; Pena, G.A.
Advances in Experimental Medicine and Biology 120b: 651-663
1979
ISSN/ISBN: 0065-2598 PMID: 229714 Document Number: 140631
Document emailed within 1 workday
Related Documents
Adams, S.; Albericio, F.; Alsina, J.; Smith, E.R.; Humphreys, R.E. 1997: Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules Arzneimittel-Forschung 47(9): 1069-1077Prozialeck, W.C.; Weiss, B. 1982: Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships Journal of Pharmacology and Experimental Therapeutics 222(3): 509-516
De Clercq, E.; Torrence, P.F. 1981: Structure-activity relationships for interferon induction and inhibition of protein synthesis by polynucleotides Texas Reports on Biology and Medicine 41: 76-83
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Reissmann, S.; Paegelow, I.; Arold, H. 1974: Connection between structure and biological activity of new bradykinin analogs Acta Biologica et Medica Germanica 33(1): 77-88
Makevnina, L.G.; Golubenko, Z.; Akhunov, A.; Paskhina, T.S. 1990: Kininase from the Latrodectus tredecimguttatus venom. Characteristics of the enzyme as a thiol endopeptidase hydrolyzing the -Pro7-Phe8- bond of bradykinin Biokhimiia 55(8): 1481-1490
Li, R.L.; Zhang, W.S.; Wang, J.C.; Poe, M. 1987: Structure-activity relationships of the inhibition of Escherichia coli dihydrofolate reductase (MB1428) by 5-(substituted phenyl) thio and 5-(substituted phenyl) seleno-2,4-diaminopyrimidines Yao Xue Xue Bao 22(3): 233-237
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542
Altomare, C.; Carotti, A.; Cellamare, S.; Carrieri, A.; Ciabatti, R.; Malabarba, A. 1994: Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships Journal of Pharmacy and Pharmacology 46(12): 994-999
Ferreira, S.H. 1994: University discoveries and intellectual property rights: from Bothrops jararaca bradykinin potentiating peptides to angiotensin converting enzyme inhibitors Brazilian Journal of Medical and Biological Research 27(8): 1693-1698
Stanković, S. 2001: X-rays in molecular biophysics: structure-activity relationships and activity of steroid hormones Medicinski Pregled 54(9-10): 413-421
Cechinel Filho, V.; Pinheiro, T.; Nunes, R.J.; Yunes, R.A.; Cruz, A.B.; Moretto, E. 1994: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships Farmaco 49(10): 675-677
Richards, R.K. 1980: Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity Archives Internationales de Pharmacodynamie et de Therapie 244(1): 107-112
Stürzebecher, J.; Markwardt, F.; Wagner, G.; Walsmann, P. 1976: Synthetic inhibitors of serine proteinases. 13. Quantitative structure-activity relationship for inhibition of trypsin and thrombin by 4-amidinophenyl compounds with a ketone structure Acta Biologica et Medica Germanica 35(12): 1665-1676
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Baillie, A.J.; Anderson, W.; Harthill, J.E. 1975: Inhibition of tryptic activity by a gastric peptide Journal of Pharmacy and Pharmacology 27(Suppl 2): 43p
Rosenkranz, H.S.; Frierson, M.R.; Klopman, G. 1986: Use of structure-activity relationships in predicting carcinogenesis Iarc Scientific Publications 1986(83): 497-517
Bowden, K.; Harris, N.V.; Watson, C.A. 1993: Structure-activity relationships of dihydrofolate reductase inhibitors Journal of ChemoTherapy 5(6): 377-388
Rietschel, E.T.; Seydel, U.; Zähringer, U.; Schade, U.F.; Brade, L.; Loppnow, H.; Feist, W.; Wang, M.H.; Ulmer, A.J.; Flad, H.D. 1991: Bacterial endotoxin: molecular relationships between structure and activity Infectious Disease Clinics of North America 5(4): 753-779